Valuation: Coloplast

Market Cap 85.99B 13.12B 11.5B 10.6B 9.93B 18.62B 1,238B 19B 127B 49.32B 612B 49.27B 48.19B 2,121B P/E 2026 *
27.4x
P/E 2027 * 14.4x
Enterprise Value 107B 16.3B 14.29B 13.17B 12.33B 23.12B 1,537B 23.6B 158B 61.26B 760B 61.2B 59.86B 2,635B EV / Sales 2026 *
3.72x
EV / Sales 2027 * 3.45x
Free-Float
63.42%
Yield 2026 *
5.33%
Yield 2027 * 5.74%
Manager TitleAgeSince
Chief Executive Officer 55 2026-04-30
Director of Finance/CFO 54 2005-12-31
Chief Operating Officer 59 2008-09-04
Director TitleAgeSince
Director/Board Member 78 2006-12-12
Director/Board Member 55 2009-09-17
Chairman 57 2025-05-04
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 13.12B
-2.32%-4.77%+62.74%+78.10% 3.65B
-2.23%-2.10%+317.69%+191.31% 3.38B
-3.77%-2.33%-32.82%-33.92% 2.29B
+4.19%+0.94%-47.14%-67.76% 1.78B
-2.97%-4.20%-29.36%-36.14% 1.71B
+0.73%-3.52%-3.52%-15.43% 1.34B
+1.81%-0.59%+26.12%+36.29% 951M
+0.12%+1.66%-14.71%-21.57% 913M
-1.49%-7.01%-39.33%-47.35% 842M
Average -0.67%-2.59%+26.63%+9.28% 1.87B
Weighted average by Cap. -0.72%-2.12%+63.21%+37.05%

Financials

2026 *2027 *
Net sales 28.74B 4.39B 3.85B 3.54B 3.32B 6.22B 414B 6.35B 42.6B 16.48B 204B 16.47B 16.11B 709B 30.69B 4.68B 4.11B 3.78B 3.54B 6.64B 442B 6.78B 45.49B 17.6B 218B 17.59B 17.2B 757B
Net income 3.15B 481M 422M 389M 364M 683M 45.4B 697M 4.68B 1.81B 22.44B 1.81B 1.77B 77.8B 5.96B 910M 798M 735M 688M 1.29B 85.8B 1.32B 8.84B 3.42B 42.41B 3.42B 3.34B 147B
Net Debt 20.81B 3.18B 2.78B 2.57B 2.4B 4.51B 300B 4.6B 30.85B 11.94B 148B 11.93B 11.67B 513B 19.87B 3.03B 2.66B 2.45B 2.29B 4.3B 286B 4.39B 29.45B 11.4B 141B 11.38B 11.14B 490B
Logo Coloplast
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - ostomy care products (35.5%): bags and equipment used following intestinal operations; - hygiene products (32.2%): urine bags, plugs, urinary testing systems and sets, etc.; - wound care and skincare products (14.1%): wound dressings, bandages, creams and gels; - interventional urology products (10%); - voice and respiratory care products (8.2%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.5%), the United States (23.5%), the United Kingdom (14%), France (10.1%), Germany (9.7%) and other (41.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA